Clinical trials for children take a European-sized step forward
Conect4children (c4c) is a pioneering collaboration between 35 academic and 10 industry partners from 20 European countries, and more than 50 third parties and around 500 affiliated partners to build capacity for the implementation of multinational paediatric clinical trials and facilitate the development of new and better treatments for paediatric patients. Find out more:
- c4c has published its first peer review publication – check out the article here.
- How can children and young patients be involved in the c4c project? A c4c video has been prepared to inform the public about the c4c network and how patients and their families can participate. It includes a brief description of activities delivered within the project that will require the participation of young patients and parents. You can watch the video here.
- A new toolkit of educational resources for patients participating in clinical trials, their families and Young Person Advisory Groups (YPAGs) is available on c4c website. This toolkit includes information and resources to help patients and their families to get started in patient and public involvement in the development of medicines, understand what a clinical trial is, what happens in a clinical trial, what ethical and legal implications are involved and what role patients and their families can play in the development of a clinical trial.
- Young patients can make an important contribution to discussions on medicines by sharing their experiences and perspectives of living with a disease or condition. The c4c team has prepared a video to inform patients on how they can contribute to the evaluation of new treatments and other regulatory environment activities at a national and European level. If you are a young person living with a disease or condition, take a look at this video and learn how you can be the voice of young EU patients.
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777389.
The Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.